Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit/Retained Earnings
Total
Balance at Dec. 31, 2019 $ 3 $ 64,402 $ (1,548) $ (6,761) $ 56,096
Balance (in shares) at Dec. 31, 2019 28,346   1,270    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation   83     83
Net income (loss)       (4,358) (4,358)
Balance at Mar. 31, 2020 $ 3 64,485 $ (1,548) (11,119) 51,821
Balance (in shares) at Mar. 31, 2020 28,346   1,270    
Balance at Dec. 31, 2019 $ 3 64,402 $ (1,548) (6,761) 56,096
Balance (in shares) at Dec. 31, 2019 28,346   1,270    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)         (3,353)
Balance at Sep. 30, 2020 $ 3 64,709 $ (1,548) (10,114) 53,050
Balance (in shares) at Sep. 30, 2020 28,375   1,270    
Balance at Mar. 31, 2020 $ 3 64,485 $ (1,548) (11,119) 51,821
Balance (in shares) at Mar. 31, 2020 28,346   1,270    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock grants   24     24
Stock grants (in shares) 13        
Stock-based compensation   79     79
Net income (loss)       (6,703) (6,703)
Balance at Jun. 30, 2020 $ 3 64,588 $ (1,548) (17,822) 45,221
Balance (in shares) at Jun. 30, 2020 28,359   1,270    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock grants   24     24
Stock grants (in shares) 16        
Stock-based compensation   97     97
Net income (loss)       7,708 7,708
Balance at Sep. 30, 2020 $ 3 64,709 $ (1,548) (10,114) 53,050
Balance (in shares) at Sep. 30, 2020 28,375   1,270    
Balance at Dec. 31, 2020 $ 3 64,826 $ (1,538) (6,614) 56,677
Balance (in shares) at Dec. 31, 2020 28,385   1,261    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   36 $ 42   78
Exercise of stock options (in shares)     (34)    
Equity offering, net $ 1 42,973     42,974
Equity offering, net (in shares) 6,917        
Stock-based compensation   124     124
Net income (loss)       (3,445) (3,445)
Balance at Mar. 31, 2021 $ 4 107,959 $ (1,496) (10,059) 96,408
Balance (in shares) at Mar. 31, 2021 35,302   1,227    
Balance at Dec. 31, 2020 $ 3 64,826 $ (1,538) (6,614) 56,677
Balance (in shares) at Dec. 31, 2020 28,385   1,261    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)         6,658
Balance at Sep. 30, 2021 $ 4 108,586 $ (1,311) 44 107,323
Balance (in shares) at Sep. 30, 2021 35,302   1,075    
Balance at Mar. 31, 2021 $ 4 107,959 $ (1,496) (10,059) 96,408
Balance (in shares) at Mar. 31, 2021 35,302   1,227    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   104 $ 185   289
Exercise of stock options (in shares)     (152)    
Stock-based compensation   199     199
Net income (loss)       5,484 5,484
Balance at Jun. 30, 2021 $ 4 108,262 $ (1,311) (4,575) 102,380
Balance (in shares) at Jun. 30, 2021 35,302   1,075    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation   324     324
Net income (loss)       4,619 4,619
Balance at Sep. 30, 2021 $ 4 $ 108,586 $ (1,311) $ 44 $ 107,323
Balance (in shares) at Sep. 30, 2021 35,302   1,075